Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like Cambridge's AVROBIO Lands $60M to Push Fabry, Rest of Pipeline Into the Clinic January 31, 2018 SAGE Therapeutics Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test September 11, 2017 Medtronic Confirms Recall of Its StrataMR Adjustable Valves and Shunts April 6, 2017